These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 12944478)

  • 1. Inhibition of retinoblastoma protein degradation by interaction with the serpin plasminogen activator inhibitor 2 via a novel consensus motif.
    Darnell GA; Antalis TM; Johnstone RW; Stringer BW; Ogbourne SM; Harrich D; Suhrbier A
    Mol Cell Biol; 2003 Sep; 23(18):6520-32. PubMed ID: 12944478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of integrated human papillomavirus type 18 oncogene transcription in cells expressing SerpinB2.
    Darnell GA; Antalis TM; Rose BR; Suhrbier A
    J Virol; 2005 Apr; 79(7):4246-56. PubMed ID: 15767426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes.
    Helt AM; Galloway DA
    J Virol; 2001 Aug; 75(15):6737-47. PubMed ID: 11435552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The C-D interhelical domain of the serpin plasminogen activator inhibitor-type 2 is required for protection from TNF-alpha induced apoptosis.
    Dickinson JL; Norris BJ; Jensen PH; Antalis TM
    Cell Death Differ; 1998 Feb; 5(2):163-71. PubMed ID: 10200461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction of an RRHR motif into chicken urokinase-type plasminogen activator (ch-uPA) confers sensitivity to plasminogen activator inhibitor (PAI)-1 and PAI-2 and allows ch-uPA-mediated extracellular matrix degradation to be controlled by PAI-1.
    Sipley JD; Alexander DS; Testa JE; Quigley JP
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):2933-8. PubMed ID: 9096324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The exon 3 encoded sequence of the intracellular serine proteinase inhibitor plasminogen activator inhibitor 2 is a protein binding domain.
    Jensen PH; Jensen TG; Laug WE; Hager H; Gliemann J; Pepinsky B
    J Biol Chem; 1996 Oct; 271(43):26892-9. PubMed ID: 8900173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The undecided serpin. The ins and outs of plasminogen activator inhibitor type 2.
    Medcalf RL; Stasinopoulos SJ
    FEBS J; 2005 Oct; 272(19):4858-67. PubMed ID: 16176260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The serine protease inhibitors TLCK and TPCK react with the RB-binding core of HPV-18 E7 protein and abolish its RB-binding capability.
    Stöppler H; Stöppler MC; Adduci A; Koval D; Schlegel R
    Virology; 1996 Mar; 217(2):542-53. PubMed ID: 8610446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The serine proteinase inhibitor (serpin) plasminogen activation inhibitor type 2 protects against viral cytopathic effects by constitutive interferon alpha/beta priming.
    Antalis TM; La Linn M; Donnan K; Mateo L; Gardner J; Dickinson JL; Buttigieg K; Suhrbier A
    J Exp Med; 1998 Jun; 187(11):1799-811. PubMed ID: 9607921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator inhibitor type-2 (PAI-2) in human keratinocytes regulates pericellular urokinase-type plasminogen activator.
    Reinartz J; Schaefer B; Bechtel MJ; Kramer MD
    Exp Cell Res; 1996 Feb; 223(1):91-101. PubMed ID: 8635500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor type 2 contains mRNA instability elements within exon 4 of the coding region. Sequence homology to coding region instability determinants in other mRNAs.
    Tierney MJ; Medcalf RL
    J Biol Chem; 2001 Apr; 276(17):13675-84. PubMed ID: 11278713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of plasminogen activator inhibitor-2 (PAI-2) in keratinocyte differentiation.
    Jang S; Yang TH; An EJ; Yoon HK; Sohn KC; Cho AY; Ryu EK; Park YS; Yoon TY; Lee JH; Kim CD
    J Dermatol Sci; 2010 Jul; 59(1):25-30. PubMed ID: 20494554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for serpinB2-independent protection from TNF-alpha-induced apoptosis.
    Fish RJ; Kruithof EK
    Exp Cell Res; 2006 Feb; 312(3):350-61. PubMed ID: 16330024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product.
    Münger K; Werness BA; Dyson N; Phelps WC; Harlow E; Howley PM
    EMBO J; 1989 Dec; 8(13):4099-105. PubMed ID: 2556261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2F1-mediated transcriptional inhibition of the plasminogen activator inhibitor type 1 gene.
    Koziczak M; Müller H; Helin K; Nagamine Y
    Eur J Biochem; 2001 Sep; 268(18):4969-78. PubMed ID: 11559366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting mechanism of the retinoblastoma tumor suppressor by a prototypical viral oncoprotein. Structural modularity, intrinsic disorder and phosphorylation of human papillomavirus E7.
    Chemes LB; Sánchez IE; Smal C; de Prat-Gay G
    FEBS J; 2010 Feb; 277(4):973-88. PubMed ID: 20088881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The canine papillomavirus and gamma HPV E7 proteins use an alternative domain to bind and destabilize the retinoblastoma protein.
    Wang J; Zhou D; Prabhu A; Schlegel R; Yuan H
    PLoS Pathog; 2010 Sep; 6(9):e1001089. PubMed ID: 20824099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An AU-rich sequence in the 3'-UTR of plasminogen activator inhibitor type 2 (PAI-2) mRNA promotes PAI-2 mRNA decay and provides a binding site for nuclear HuR.
    Maurer F; Tierney M; Medcalf RL
    Nucleic Acids Res; 1999 Apr; 27(7):1664-73. PubMed ID: 10075998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins.
    Dick FA; Sailhamer E; Dyson NJ
    Mol Cell Biol; 2000 May; 20(10):3715-27. PubMed ID: 10779361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.